Understand the source comparison
Is Semax Amidate Legal: Regulatory Comparison
The table below compares Semax amidate legal status across key jurisdictions and use contexts, clarifying where possession, research use, and clinical administration are permitted or restricted. United States Unscheduled No FDA approval Yes. With research labe
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The table below compares Semax amidate legal status across key jurisdictions and use contexts, clarifying where possession, research use, and clinical administration are permitted or restricted.
- United States
- Unscheduled
- No FDA approval
- Yes. With research labeling
- No. Requires IND application
- No
- Legal to possess for research; illegal to market for human use without FDA approval
- Russia
- Not applicable
- Approved pharmaceutical
- Yes
- Yes. With prescription
- Yes. For stroke, cognitive disorders
- Fully legal as prescription medication; developed domestically
- European Union
- Not scheduled
- No EMA approval
- Yes. Research exemption
- No. Investigational only
- Same as US. Research permitted, clinical use prohibited
- Australia
- Schedule 4
- Not approved by TGA
- Restricted. Import permits may be required
- No. No approved indication
- Theoretically yes, but no indication exists
- Tighter import controls; prescription-only classification without clinical pathway
- Canada
- No Health Canada approval
- No. Clinical trial authorization required
- Research use allowed; human administration requires regulatory submission